|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 - code c19: review of device manufacturing record history confirmed device met pre-release specifications.H6 - code b18: the device was discarded at the treating facility and was, therefore, not available for analysis.No images enabling direct assessment of product performance were returned for evaluation.Ifu warnings state: do not withdraw the gore® viabahn® vbx balloon expandable endoprosthesis back into the introducer sheath once the endoprosthesis is fully introduced.Withdrawing the gore® viabahn® vbx balloon expandable endoprosthesis back into the sheath can cause dislocation and / or damage to the endoprosthesis, premature deployment, deployment failure, and / or catheter separation.If removal prior to deployment is necessary, withdraw the gore® viabahn® vbx balloon expandable endoprosthesis to a position close to but not into the introducer sheath.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
The following was reported to gore: on (b)(6) 2026, during an iliac branch endoprosthesis (ibe) procedure a 12fr x 26cm gore® dryseal flex introducer sheath (dsf) was used to advance a gore® viabahn® vbx balloon expandable endoprosthesis (vbx stent) to the left hypogastric artery.As reported, there was a pre-existing endurant stent at the intended treatment site.It was reported the vbx stent had to be retracted because the wire and sheath prolapsed into the existing evar device to the point that vbx stent pushability was lost.As the vbx stent was retracted back into the dsf, the vbx stent dislodged from the balloon in the trunk of the evar device.The physician was able to snare the constrained vbx stent and remove it from the patient with no issues.A new vbx device was advanced and deployed.The procedure ended with good outcome.The patient did not experience any adverse consequences.
|